Hints and tips:
...The price/earnings ratio of Edwards Lifesciences and Terumo are a third higher. Even a small refocusing of Olympus’s image could lead to handsome gains....
...(WSJ) “Yahoo chief Marissa Mayer will seek to fend off a challenge from activist investor Starboard Value LP this week by detailing her plan for turning around the struggling Internet business....
...Permira’s last deal, the Y100bn acquisition of Tokyo-based Arysta LifeScience in October 2007, was another secondary buyout, from a Hong Kong-based investment group....
...The rise was fuelled by rising stock markets, as well as higher profits and reduced debts at Permira’s biggest deals, such as Japanese agrichemicals maker Arysta LifeScience, Danish telecom operator TDC,...
...This showed it was prepared to be patient in Asia, as it opened the Japanese office in 2005 and only completed its first deal there last year with the $2.2bn buy-out of Arysta LifeSciences....
...Last month Permira, the UK-based private equity fund, snapped up Arysta LifeScience, a Tokyo-based agribusiness, for $2.2bn – the biggest such deal this year....
...Permira, the UK buy-out group, last month agreed to buy Arysta LifeScience, a Japanese agrobusiness, in a deal worth $2.2bn....
...Hot on the heels of Permira’s $2.2bn deal to buy Japan’s Arysta LifeScience comes the consortium bid on Monday for Australia’s Nufarm, valued at up to A$3bn ($2.76bn)....
International Edition